The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized clinical trial of preoperative chemoradiotherapy by S-1 versus UFT to rectal cancer for personalized therapy.
Tomohiko Miyatani
No relevant relationships to disclose
Toru Utsunomiya
No relevant relationships to disclose
Nobuhiro Kurita
No relevant relationships to disclose
Takashi Iwata
No relevant relationships to disclose
Hirohiko Sato
No relevant relationships to disclose
Masanori Nishioka
No relevant relationships to disclose
Shinya Morimoto
No relevant relationships to disclose
Kozo Yoshikawa
No relevant relationships to disclose
Jun Higashijima
No relevant relationships to disclose
Hideya Kashihara
No relevant relationships to disclose
Chie Mikami
No relevant relationships to disclose
Mitsuo Shimada
Research Funding - Taiho Pharmaceutical